Hepatitis C Management in Special Populations

  • Author: Mark S. Sulkowski, MD (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 8/17/18 (What's New)

Summary

  • Women of reproductive age who have been diagnosed with HCV infection should be counseled about the benefit of antiviral treatment before pregnancy
  • Safety and efficacy of DAAs in pregnancy is unknown, and there are no data on the effect of DAAs on male or female fertility

Action required